EIF4EBP1 and urinary bladder carcinoma: We found that phosphorylation of EIF4EBP1 was significantly reduced in the TalaA-treated group, indicating that TalaA inhibits translation in bladder cancer cells by downregulating EIF4EBP1 phosphorylation.